Abstract:e15272 Background: Interferon alpha (IFNa) has been used to treat a variety of tumors, but its efficacy in the treatment of solid tumors has been significantly hindered by relatively low antitumor efficacy and numerous side effects. In the former work, we found a number of ‘interferon enhancer peptides’ (IEP) and selected a short positive charged peptide derived from the C-terminal of placental growth factor-2 (PLGF-2). In this study we explored whether this novel PLGF-2 IEP was able to potentiate the antitumor activity of IFNa. Methods: We constructed a synthetic Interferon alpha hybrid molecule (SIFa) by fusing the PLGF-2 IEP to the C-terminus of human IFNa. Using the human pancreatic cancer cell lines (ASPC and CFPAC-1) as a model system. After transfection of SIFa via lentivirus vector, ELISA was used to detect the secretion. The effect of SIFa on the proliferation of pancreas cancer cells was examined in vitro by using sulforhodamine B and cell cycle analysis. We also examined the effect of SIFa combining with gemcitabin (GEM) and the impact of SIFa on interferon pathway target genes, RT–PCR was performed. Results: The pancreatic cancer cells with the SIFa stably secreted high level of IFNa (48h: 285±21 pg/ml for ASPC; 48h: 535±13 pg/ml for CFPAC-1). We found that the SIFa exhibited a significantly higher activity than the IFNa in inhibiting cancer cells growth (the inhibition ratio: 44.6% vs 28.0% for ASPC; 53.5% vs 40.7% for CFPAC-1; p < 0.05). The SIFa inhibited cells growth by decreasing the proportion of G0/G1 phase cells compared with the IFNa (the percentage of G0/G1: 49.5%±0.8% vs 53.6%±0.6% for ASPC; 58.9%±0.9% vs 63.4%±0.6% for CFPAC-1; p < 0.05). Meanwhile, we found that the SIFa showed a significantly higher inhibition than IFNa in potentiating the inhibition of cells growth induced by GEM (66.9% vs 38.3% for ASPC; 87.8% vs 66.1% for CFPAC-1; p < 0.05). The enhanced antitumor activity of the synthetic SIFa was correlated with the activation of interferon pathway target genes MX1, IFIT1 and OAS2. Conclusions: The synthetic IFNa/PLGF-2 IEP enhanced antitumor activity in pancreatic cancer cells in vitro through activating of interferon pathway target genes. This study demonstrates the potential of the synthetic SIFa as a novel antitumor agent.

Interferon-α in Combination with Chemotherapy Has Potent Antiangiogenic Properties in an Orthotopic Mouse Model for Pancreatic Adenocarcinoma

Interferon-alpha enhances antitumor effect of chemotherapy in an orthotopic mouse model for pancreatic adenocarcinoma.

Radiofrequency Hyperthermia Enhances Locally Delivered Oncolytic Immuno-Virotherapy for Pancreatic Adenocarcinoma

Combination Doxorubicin And Interferon-Alpha Therapy Stimulates Immunogenicity Of Murine Pancreatic Cancer Panc02 Cells Via Up-Regulation Of Nkg2d Ligands And Mhc Class I

Intratumoral Radiofrequency Hyperthermia-Enhanced Direct Chemotherapy of Pancreatic Cancer

The Underlying Molecular Mechanism of Intratumoral Radiofrequency Hyperthermia-Enhanced Chemotherapy of Pancreatic Cancer

Influence of Interferon-Α on the Expression of the Cancer Stem Cell Markers in Pancreatic Carcinoma Cells.

Intratumoral Injection of Interferon Gamma Promotes the Efficacy of Anti-Pd1 Treatment in Colorectal Cancer

Combinational Therapy of Interferon-Α and Chemotherapy Normalizes Tumor Vasculature by Regulating Pericytes Including the Novel Marker RGS5 in Melanoma.

IFN-γ Down-Regulates the PD-1 Expression and Assist Nivolumab in PD-1-blockade Effect on CD8+ T-lymphocytes in Pancreatic Cancer

The Antitumor Activity Of Synthetic Interferon-Alpha In Pancreatic Cancer Cells.

Antitumor Efficacy of Combination of Interferon-Gamma-inducible Protein 10 Gene with Gemcitabine, a Study in Murine Model

Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment

[Antitumor Effects of Interferon-Gamma-inducible Protein 10 Combined with Gemcitabine].

Antitumor Potential of A Synthetic Interferon-Alpha/Plgf-2 Positive Charge Peptide Hybrid Molecule in Pancreatic Cancer Cells

Adenovirus‐mediated Interferon‐γ Gene Therapy Induced Human Pancreatic Carcinoma Capan‐2 Cell Apoptosis in Vitro and in Vivo

Efficacy of Tumor-Targeting Salmonella Typhimurium A1-R in Combination with Anti-Angiogenesis Therapy on A Pancreatic Cancer Patient-Derived Orthotopic Xenograft (pdox) and Cell-Line Mouse Models

Combination therapy with interleukin-15 and metformin as a synergistic treatment for pancreatic cancer

Interferon-α Combined with Herbal Compound "songyou Yin" Effectively Inhibits the Increased Invasiveness and Metastasis by Insufficient Radiofrequency Ablation of Hepatocellular Carcinoma in an Animal Model.

Synergistic Antitumor Effect of Adenovirus-Mediated Hing4 Gene Therapy and (125)I Radiation Therapy on Pancreatic Cancer.

Investigation of an anticancer activity of combination of interferon-alpha and gemcitabine on pancreatic cancer cells